1-3 of 3
Wanling Xie, MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Time to Development of Treatment-Emergent Extramedullary and Osseous Plasmacytomas in the Era of Novel Agents: An Analysis of Upfront Regimens in Newly Diagnosed MM Incorporating Lenalidomide and Bortezomib

Cindy Varga, Jacob P. Laubach, MD, Irene M. Ghobrial, MD, Matthew Weinstock, MD, Claudia E. Paba-Prada, MD, Robert L. Schlossman, MD, Nikhil Munshi, Wanling Xie, MS, Edie A. Weller, PhD, Kenneth C. Anderson, MD, Constantine S. Mitsiades, MD PhD, Paul G. Richardson
Journal: Blood
Blood (2014) 124 (21): 3468.
https://doi.org/10.1182/blood.V124.21.3468.3468
Published: 2014
Journal Articles

Assessment Of Drug Toxicity In Patients With and Without Renal Impairment Receiving Lenalidomide At a Large Academic Institution

Houry Leblebjian, PharmD, BCOP, Wanling Xie, MS, Paul G. Richardson, MD, Irene M. Ghobrial, MD, Christy Harris, PharmD, BCPS, BCOP, Robert L Schlossman, MD, Claudia E. Paba-Prada, MD, Nikhil C. Munshi, MD, Sylvia Bartel, R.Ph., M.H.P., Kenneth C. Anderson, MD, Edie A. Weller, PhD, Jacob P. Laubach, MD
Journal: Blood
Blood (2013) 122 (21): 1977.
https://doi.org/10.1182/blood.V122.21.1977.1977
Published: 2013
Journal Articles

The Role of Serum Immunoglobulin Free Light Chain In Response and Progression In Waldenstrom Macroglobulinemia

Xavier Leleu, MD, PhD, Wanling Xie, MS, Meghan Rourke, Ranjit Banwait, Renee Leduc, Nitin Roper, Edie Weller, Irene Ghobrial, MD
Journal: Blood
Blood (2010) 116 (21): 3095.
https://doi.org/10.1182/blood.V116.21.3095.3095
Published: 2010